JP2022539417A5 - - Google Patents
Info
- Publication number
- JP2022539417A5 JP2022539417A5 JP2022500009A JP2022500009A JP2022539417A5 JP 2022539417 A5 JP2022539417 A5 JP 2022539417A5 JP 2022500009 A JP2022500009 A JP 2022500009A JP 2022500009 A JP2022500009 A JP 2022500009A JP 2022539417 A5 JP2022539417 A5 JP 2022539417A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025119400A JP2025157393A (ja) | 2019-07-02 | 2025-07-16 | Ｈｉｖ抗原及びｍｈｃ複合体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962869877P | 2019-07-02 | 2019-07-02 | |
| US62/869,877 | 2019-07-02 | ||
| US202063029981P | 2020-05-26 | 2020-05-26 | |
| US63/029,981 | 2020-05-26 | ||
| PCT/US2020/040630 WO2021003348A1 (en) | 2019-07-02 | 2020-07-02 | Hiv antigens and mhc complexes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025119400A Division JP2025157393A (ja) | 2019-07-02 | 2025-07-16 | Ｈｉｖ抗原及びｍｈｃ複合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539417A JP2022539417A (ja) | 2022-09-08 |
| JPWO2021003348A5 JPWO2021003348A5 (https=) | 2023-07-07 |
| JP2022539417A5 true JP2022539417A5 (https=) | 2023-07-07 |
Family
ID=74101141
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500009A Pending JP2022539417A (ja) | 2019-07-02 | 2020-07-02 | Ｈｉｖ抗原及びｍｈｃ複合体 |
| JP2025119400A Pending JP2025157393A (ja) | 2019-07-02 | 2025-07-16 | Ｈｉｖ抗原及びｍｈｃ複合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025119400A Pending JP2025157393A (ja) | 2019-07-02 | 2025-07-16 | Ｈｉｖ抗原及びｍｈｃ複合体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20220265812A1 (https=) |
| EP (1) | EP3993829A4 (https=) |
| JP (2) | JP2022539417A (https=) |
| KR (1) | KR20220041844A (https=) |
| CN (1) | CN114340661A (https=) |
| AU (1) | AU2020298552A1 (https=) |
| CA (1) | CA3145833A1 (https=) |
| WO (1) | WO2021003348A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019013259A (es) | 2017-05-08 | 2020-01-13 | Gritstone Oncology Inc | Vectores de neoantigeno de alfavirus. |
| MX2021014525A (es) | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| CN114761041A (zh) | 2019-07-16 | 2022-07-15 | 吉利德科学公司 | Hiv疫苗及其制备和使用方法 |
| CN115917654A (zh) * | 2020-04-21 | 2023-04-04 | 瑞泽恩制药公司 | 用于分析受体相互作用的方法和系统 |
| KR20230046313A (ko) | 2020-08-06 | 2023-04-05 | 그릿스톤 바이오, 인코포레이티드 | 다중에피토프 백신 카세트 |
| EP4277652A1 (en) | 2021-01-14 | 2023-11-22 | Gilead Sciences, Inc. | Hiv vaccines and methods of using |
| CA3246299A1 (en) * | 2022-04-08 | 2023-10-12 | Seattle Project Corp. | ANTIGEN PREDICTIONS FOR EPITOPES DERIVED FROM INFECTIOUS DISEASES |
| WO2024144267A1 (ko) * | 2022-12-27 | 2024-07-04 | (주)한국바이오셀프 | Hiv-1 mrna를 포함하는 백신 조성물 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050271676A1 (en) * | 1993-03-05 | 2005-12-08 | Epimmune Inc. | Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| EP1000628A1 (en) * | 1998-09-28 | 2000-05-17 | Fondation Mondiale Recherche et Prevention SIDA | Use of antigenic complexes of HIV envelope and HLA class I antigens as HIV vaccine |
| JP4461350B2 (ja) * | 1999-05-28 | 2010-05-12 | 味の素株式会社 | Ｈｉｖ特異的ｃｔｌを誘導し得るペプチド及び該ペプチドを含む抗ａｉｄｓ予防・治療剤 |
| WO2001027291A1 (en) * | 1999-10-12 | 2001-04-19 | Institut Pasteur | Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice |
| AU784679B2 (en) * | 1999-12-23 | 2006-05-25 | International Aids Vaccine Initiative | Improvements in or relating to immune responses to HIV |
| CA2397998A1 (en) * | 2000-01-28 | 2001-08-02 | Statens Serum Institut | Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| CU23235A1 (es) * | 2001-02-28 | 2007-09-26 | Ct Ingenieria Genetica Biotech | POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA |
| ATE401392T1 (de) * | 2004-10-04 | 2008-08-15 | Biovaxim Ltd | Subtypabgestimmte inaktivierte vollvirusvakzine zur behandlung von patienten mit hiv-infektion |
| FR2882557A1 (fr) * | 2005-02-25 | 2006-09-01 | Centre Nat Rech Scient | Epitopes de vih et composition pharmaceutique les contenant |
| NZ575901A (en) * | 2006-09-12 | 2012-04-27 | Alphavax Inc | Alphavirus replicon particles matched to protein antigens as immunological adjuvants |
| WO2010037402A1 (en) * | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| US20170360920A1 (en) * | 2014-11-20 | 2017-12-21 | The Johns Hopkins University | Method and compositions for the prevention and treatment of a hiv infection |
| RU2729116C2 (ru) * | 2015-12-16 | 2020-08-04 | Гритстоун Онколоджи, Инк. | Идентификация, производство и применение неоантигенов |
| PE20191345A1 (es) * | 2016-11-23 | 2019-09-30 | Gritstone Oncology Inc | Administracion viral de neoantigenos |
| KR102841050B1 (ko) * | 2017-04-19 | 2025-08-01 | 그릿스톤 바이오, 인코포레이티드 | 신생항원 동정, 제조, 및 용도 |
| MX2019013259A (es) * | 2017-05-08 | 2020-01-13 | Gritstone Oncology Inc | Vectores de neoantigeno de alfavirus. |
-
2020
- 2020-07-02 CA CA3145833A patent/CA3145833A1/en active Pending
- 2020-07-02 JP JP2022500009A patent/JP2022539417A/ja active Pending
- 2020-07-02 EP EP20835351.6A patent/EP3993829A4/en active Pending
- 2020-07-02 WO PCT/US2020/040630 patent/WO2021003348A1/en not_active Ceased
- 2020-07-02 KR KR1020227003297A patent/KR20220041844A/ko active Pending
- 2020-07-02 CN CN202080059796.1A patent/CN114340661A/zh active Pending
- 2020-07-02 AU AU2020298552A patent/AU2020298552A1/en active Pending
-
2021
- 2021-12-29 US US17/564,920 patent/US20220265812A1/en not_active Abandoned
-
2022
- 2022-08-03 US US17/817,312 patent/US20230128001A1/en active Pending
-
2025
- 2025-07-16 JP JP2025119400A patent/JP2025157393A/ja active Pending